Publications by authors named "Tim Price"

Claim this Profile
A
AI-Based Virtual Triage and Telemedical Health Care for Ukrainian War Refugees and Displaced Persons.
George A Gellert, Kacper Kuszczynski, Gabriel L Gellert, Aleksandra Kabat-Karabon, Anna Nowicka, Tim Price

JAMA Netw Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographics, Comorbidities, and Care-Seeking Intent Among Individuals with Obesity or Overweight Status Using Outpatient AI-Based Virtual Triage.
George A Gellert, Anna Nowicka, Maria Marecka, Gabriel L Gellert, Tim Price

Telemed Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer.
Nick Pavlakis, Kohei Shitara, Katrin Sjoquist, Andrew Martin, Anthony Jaworski, Tim Price

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of virtual triage AI to improve early detection, care acuity alignment, and emergent care referral of life-threatening conditions.
George A Gellert, Aleksandra Kabat-Karabon, Gabriel L Gellert, Joanna Rasławska-Socha, Stanislaw Gorski, Tim Price

Front Public Health· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Virtual Triage Can Improve Patient Experience and Satisfaction: A Narrative Review and Look Forward.
George A Gellert, Joanna Rasławska-Socha, Natalia Marcjasz, Tim Price, Kacper Kuszczyński

Telemed Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Virtual Triage in Improving Clinician Experience and Satisfaction: A Narrative Review.
George A Gellert, Joanna Rasławska-Socha, Natalia Marcjasz, Tim Price, Alicja Heyduk

Telemed Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multinational survey of patient utilization of and value conveyed through virtual symptom triage and healthcare referral.
George A Gellert, Piotr M Orzechowski, Tim Price, Aleksandra Kabat-Karabon, Jakub Jaszczak

Front Public Health· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions diverge on aspects related to substance use disorder: An analysis of individuals in recovery, physicians, nurses, and medical students.
Jacob Shreffler, Isaac Shaw, Suzanne McGee, Campbell Bishop, Selena Thé, Tim Price

Subst Abus· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models.
Maryam Nakhjavani, Eric Smith, Helen M Palethorpe, Yoko Tomita, Kenny Yeo, Tim J Price

Pharmaceuticals (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments.
Maryam Nakhjavani, Eric Smith, Kenny Yeo, Helen M Palethorpe, Yoko Tomita, Tim J Price

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of early-stage gastro-esophageal cancers: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.
Amitesh C Roy, Jeremy Shapiro, Matt Burge, Christos S Karapetis, Nick Pavlakis, Tim Price

Expert Rev Anticancer Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer.
Maryam Nakhjavani, Jennifer E Hardingham, Helen M Palethorpe, Tim J Price, Amanda R Townsend

J Breast Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer.
Maryam Nakhjavani, Jennifer E Hardingham, Helen M Palethorpe, Yoko Tomita, Eric Smith, Tim J Price

Medicines (Basel)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pressure dressings in mastoid and middle ear surgery: are they necessary? A retrospective review of patient outcomes.
Justin Xavier O'Brien, Olivia Ruskin, Tim Price

ANZ J Surg· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma.
Andrew J Martin, Emma Gibbs, Katrin Sjoquist, Nick Pavlakis, John Simes, Tim Price

Gastric Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.
Manju D Chandrasegaram, Anthony J Gill, Jas Samra, Tim Price, John Chen

World J Gastrointest Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.
Jeanne Tie, Yuxuan Wang, Cristian Tomasetti, Lu Li, Simeon Springer, Tim J Price

Sci Transl Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.
Eva Segelov, Paul Waring, Jayesh Desai, Kate Wilson, Val Gebski, Tim Price

BMC Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors.
Stephen J Clarke, Christos S Karapetis, Peter Gibbs, Nick Pavlakis, Jayesh Desai, Tim J Price

Crit Rev Oncol Hematol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of cancers of the kidney in an Australian population.
Colin Luke, Nicole Sargent, Ken Pittman, Tim Price, David Roder

Asian Pac J Cancer Prev· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer.
Andrew J Weickhardt, Tim J Price, Geoff Chong, Val Gebski, Nick Pavlakis

J Clin Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic carcinoid tumor: changing patterns of care over two decades.
Amanda Townsend, Tim Price, Sue Yeend, Ken Pittman, Kevin Patterson

J Clin Gastroenterol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today?
Marc Peeters, Tim Price, Jean-Luc Van Laethem

Oncologist· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of two-dimensional 2:1 cation-ordered perovskite units by anion vacancy ordering in Ba6Na2Nb2P2O17.
Xiaojun Kuang, John B Claridge, Tim Price, David M Iddles, Matthew J Rosseinsky

Inorg Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
Colin Luke, Bogda Koczwara, Christos Karapetis, Ken Pittman, Tim Price

Aust N Z J Public Health· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis